Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Leaderboard Analytics
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Lowe v. Walgreens Boots Alliance, Inc. et al
Case Number:
3:21-cv-02852
Court:
Nature of Suit:
Multi Party Litigation:
Class Action
Judge:
Firms
Companies
Sectors & Industries:
-
September 24, 2021
Walgreens Escapes 'Pink Tax' Suit Over Hair Loss Meds
A California federal court has tossed a proposed class action against Walgreens by a shopper accusing the company of charging a "pink tax" on women's hair loss products, finding that the pharmacy chain can't deviate on the labeling approved by the U.S. Food and Drug Administration.
-
September 13, 2021
Judge Doubts 'Pink Tax' Suit Over Walgreens Hair-Loss Meds
A California magistrate judge appeared open Monday to tossing a Walgreens shopper's proposed class action accusing the pharmacy chain of charging a so-called pink tax on women's hair-loss treatment, saying she's "struggling" with the claims because women aren't prohibited from buying the men's products that cost half the price.
-
April 20, 2021
Walgreens Hit With 'Pink Tax' Suit Over Hair-Loss Meds
A consumer hit Walgreens with a proposed class action Tuesday in California federal court, accusing the pharmacy chain of charging a so-called pink tax on women's hair-loss treatment even though the product is the same as treatments marketed to men that cost a fraction of the price.